Actinium Pharmaceuticals updates Actimab-A IP, manufacturing and NYSE listing
Actinium Pharmaceuticals (ATNM) announces Actimab-A intellectual property and manufacturing advances and provides an update on its NYSE American listing.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.